JP2001518516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001518516A5 JP2001518516A5 JP2000514666A JP2000514666A JP2001518516A5 JP 2001518516 A5 JP2001518516 A5 JP 2001518516A5 JP 2000514666 A JP2000514666 A JP 2000514666A JP 2000514666 A JP2000514666 A JP 2000514666A JP 2001518516 A5 JP2001518516 A5 JP 2001518516A5
- Authority
- JP
- Japan
- Prior art keywords
- gdf
- antibody
- inhibitor
- fragment
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/946,092 US6030617A (en) | 1993-01-12 | 1997-10-06 | Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| US08/946,092 | 1997-10-06 | ||
| PCT/US1998/021199 WO1999017797A1 (en) | 1997-10-06 | 1998-10-06 | Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001518516A JP2001518516A (ja) | 2001-10-16 |
| JP2001518516A5 true JP2001518516A5 (https=) | 2006-01-05 |
Family
ID=25483945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000514666A Pending JP2001518516A (ja) | 1997-10-06 | 1998-10-06 | 避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6030617A (https=) |
| EP (1) | EP1021201A4 (https=) |
| JP (1) | JP2001518516A (https=) |
| AU (1) | AU757563B2 (https=) |
| CA (1) | CA2306452A1 (https=) |
| WO (1) | WO1999017797A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1181041A2 (en) * | 1999-04-30 | 2002-02-27 | Curis, Inc. | Morphogen-induced enhancement of fertility |
| NZ502796A (en) * | 2000-06-15 | 2003-02-28 | Agres Ltd | Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9 |
| NZ519330A (en) * | 2002-05-30 | 2004-12-24 | George Henry Davis | New sequences for altering mammalian ovarian function and ovulation rate |
| JP2008521891A (ja) * | 2004-12-02 | 2008-06-26 | アグリサーチ・リミテッド | 排卵の調節 |
| WO2007009166A1 (en) * | 2005-07-18 | 2007-01-25 | Adelaide Research & Innovation Pty Ltd | Modulation of granulosa cell apoptosis |
| US7790161B2 (en) * | 2006-03-28 | 2010-09-07 | Wyeth Llc | GDF-9/BMP-15 modulators for the treatment of bone disorders |
| EP3577457A4 (en) * | 2017-02-01 | 2021-01-20 | Robert Bruce Gilchrist | GROWTH FACTORS SECRETED BY GAMETES |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0678101A4 (en) * | 1993-01-12 | 1997-07-16 | Univ Johns Hopkins Med | FACTOR-9 OF GROWTH AND DIFFERENTIATION. |
| EP0725796A4 (en) * | 1993-10-08 | 1999-12-01 | Univ Johns Hopkins | Growth differentiation factor-10 |
| US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
-
1997
- 1997-10-06 US US08/946,092 patent/US6030617A/en not_active Expired - Lifetime
-
1998
- 1998-10-06 EP EP98953308A patent/EP1021201A4/en not_active Ceased
- 1998-10-06 WO PCT/US1998/021199 patent/WO1999017797A1/en not_active Ceased
- 1998-10-06 CA CA002306452A patent/CA2306452A1/en not_active Abandoned
- 1998-10-06 JP JP2000514666A patent/JP2001518516A/ja active Pending
- 1998-10-06 AU AU10714/99A patent/AU757563B2/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stanislaus et al. | Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin | |
| Fink et al. | Intrapancreatic interleukin-1β gene expression by specific leukocyte populations during acute pancreatitis | |
| Polman et al. | Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat | |
| JP2003517461A5 (https=) | ||
| JP2002531421A5 (https=) | ||
| KR880000098A (ko) | 콘드로이틴 설페이트 면역자극 조성물 | |
| WO2005113007A3 (de) | Pulver enthaltend neuartige oligosaccharidgemische und verfahren zu deren herstellung | |
| JP2001518516A5 (https=) | ||
| LU88684I2 (fr) | Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet ) | |
| BR0306732A (pt) | Tratamentos em combinação para doença alérgica compreendendo a administração de um anticorpo anti-ige e composto antialérgico | |
| JP2004500325A5 (https=) | ||
| JP2006508039A5 (https=) | ||
| US5660826A (en) | Therapeutic sepsis treatment using antagonists to PTHrP | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| CA2452986A1 (en) | Use of polyclonal anti-hiv goat serum as a therapeutic agent | |
| JP3176051B2 (ja) | 避妊方法とその組成物 | |
| WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
| EP0955366A4 (en) | ANTIGENIC PROTEIN FROM MALASSEZIA | |
| PH26708A (en) | Physiologically active compositions containing anti-hormone anti-bodies and their use | |
| Baran et al. | Current practices: immunosuppression induction, maintenance, and rejection regimens in contemporary post-heart transplant patient treatment | |
| WO2000001729A3 (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome | |
| Weisberger et al. | Suppression of antibody synthesis by chloramphenicol analogs | |
| D'amore et al. | Reduced antinociceptive response to beta-endorphin in adult mice after chronic neonatal handling | |
| JP2000053580A (ja) | 全身性紅斑性狼そうの治療におけるペプチド化合物の使用方法 | |
| JPH01500663A (ja) | 動物の生殖機能の調節 |